Cart
sales@molnova.com
Ginsenoside F4
CAS No. 181225-33-2
Ginsenoside F4( —— )
Catalog No. M31419 CAS No. 181225-33-2
Ginsenoside F4 has inhibitory effect on human lymphocytoma JK cell by inducing its apoptosis, the mechanism is related to the mitochondrial dysfunction and the increase of Bax expression and decrease of Bcl-2 expression.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 217 | In Stock |
|
| 10MG | 325 | In Stock |
|
| 25MG | 543 | In Stock |
|
| 50MG | 756 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGinsenoside F4
-
NoteResearch use only, not for human use.
-
Brief DescriptionGinsenoside F4 has inhibitory effect on human lymphocytoma JK cell by inducing its apoptosis, the mechanism is related to the mitochondrial dysfunction and the increase of Bax expression and decrease of Bcl-2 expression.
-
DescriptionGinsenoside F4 has inhibitory effect on human lymphocytoma JK cell by inducing its apoptosis, the mechanism is related to the mitochondrial dysfunction and the increase of Bax expression and decrease of Bcl-2 expression.
-
In VitroWestern Blot Analysis Cell Line:Human lymphocytoma JK cells Concentration:8.15 μM, 65.19 μM, 130.38 μM Incubation Time:Result:Decreased Bcl-2 protein level and increased the Bax level, which changes related to apoptosis.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number181225-33-2
-
Formula Weight767
-
Molecular FormulaC42H70O12
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (65.19 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Lushanrubescensin H
Lushanrubescensin H is a natural product from Isodon rubescens.
-
Ureidosuccinic acid
Ureidosuccinic acid is an intermediary product in pyrimidine biosynthesis.
-
Vopratelimab
Vopratelimab (JTX-2011) is a selective humanized immunoglobulin G1-kappa monoclonal antibody and a potent ICOS agonist with high affinity for inducible T cell co-stimulating factors (ICOS), showing affinities of 0.93 nM for hICOS, 3.7 nM for rat ICOS, and 0.64 nM for mICOS.
